Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Secher Ejlertsen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancers|December 11, 2022
Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional LaserSilje Haukali Omland, Jacob Secher Ejlertsen, Dorrit Krustrup, et al.
Ugeskrift for Laeger|April 13, 2026
[Digital pathology]Christian Beltoft Brøchner, Elisabeth Specht Stovgaard, Jacob Secher Ejlertsen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancers|December 11, 2022
Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional LaserSilje Haukali Omland, Jacob Secher Ejlertsen, Dorrit Krustrup, et al.
Ugeskrift for Laeger|April 13, 2026
[Digital pathology]Christian Beltoft Brøchner, Elisabeth Specht Stovgaard, Jacob Secher Ejlertsen, et al.
Pageof 1